|
Market Closed -
London S.E.
16:35:02 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1550 GBX | 0.00% |
|
0.00% | -53.73% |
| 08-10 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 08-10 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
Chart: Technical Analysis
Stock exchange
London S.E.
VAL 0.1550 p
0.00%
252K
p
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
London S.E.
| VAL | 0.1550GBX | 0.00% | 252K p | |
Deutsche Boerse AG
| EAJF | 0.000500EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| EAJF | 0.001500EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 0.165 | 0.225 | 0.31 |
| Spread/Res. | -6.06% | -31.11% | -50.00% |
| Spread/Supp. | +3.33% | +6.90% | +6.90% |
| Support | 0.15 | 0.145 | 0.145 |
- Stock Market
- Stocks
- VAL Stock
- Charts ValiRx plc
Select your edition
All financial news and data tailored to specific country editions
